The most common form of unpreventable blindness in the world, dry-AMD affects the vision of some 10 million Americans. Click here to learn more about dry-AMD and Alkeus future trials.
One of the leading causes of childhood blindness, Stargardt's disease is currently untreatable and irreversible. To stay informed of Alkeus upcoming clinical trials, click here.
Alkeus drug candidates result from years of research by leading ophthalmic scientists. Click here to learn more about vision, our scientific approach and our preclinical animal data.
Alkeus is composed of an experienced and committed leadership, and collaborates with leading physicians worldwide to ensure safe and timely clinical trials. Click here to learn more about Alkeus.
